Contera Pharma A/S
Health Care · Biotechnology

Contera Pharma A/S: Products & infrastructure

Contera Pharma A/S has 3 clinical trials on record, 0 under way.

Data updated Nov 21, 2026 · Back to the company report

Products

Contera Pharma A/S has 3 clinical trials on record, 0 under way.

3clinical trials
1EU trials (CTIS)
EU clinical trialsthe trials it sponsors, per the EU's CTIS register
A Phase 2, Multicenter, Randomized, Parallel Treatment Arms, Double-Blind, Placebo-Controlled Study to Evaluate the Eff…
Therapeutic exploratory (Phase II) · Parkinson’s Disease With Early Morning OFF Episodes · Poland, Italy, Spain
Nov 2026
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov
Open-Label Extension Study of ASTORIA
phase 2 · stopped or withdrawn · 6 participants · Dyskinesias
Jan 2024
A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia
phase 2 · completed · 89 participants · Dyskinesias
Jul 2019
Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia
phase 2 · completed · 30 participants · as a collaborator · Parkinson's Disease; Levodopa Induced Dyskinesia (LID)
May 2015
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.